Open Innovation EB Platform

EBRI supports drug development by providing open access to its translational EB models

At EBRI we have integrated preclinical platforms that allow us to accelerate discoveries and translation of scientific data. These consist of the following: EB Biobank, in vitro disease-relevant models and in vivo models that capture the complex phenotype of the disease.